Samarth Hegde
Affiliations: | Icahn School of Medicine at Mount Sinai, New York, NY, United States |
Area:
Cancer ImmunologyGoogle:
"Samarth Hegde"Parents
Sign in to add mentor| David G. DeNardo | grad student | 2014-2019 | Washington University |
| Miriam Merad | post-doc | (Cell Biology Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| LaMarche NM, Hegde S, Park MD, et al. (2023) An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis. Nature |
| Magen A, Hamon P, Fiaschi N, et al. (2023) Intratumoral dendritic cell-CD4 T helper cell niches enable CD8 T cell differentiation following PD-1 blockade in hepatocellular carcinoma. Nature Medicine |
| Park MD, Reyes-Torres I, LeBerichel J, et al. (2023) TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer. Nature Immunology |
| Hegde S. (2021) Pancreatic Cancer Immuno-oncology in the Era of Precision Medicine. Indian Journal of Surgical Oncology. 12: 118-127 |
| Hegde S, Leader AM, Merad M. (2021) MDSC: Markers, development, states, and unaddressed complexity. Immunity. 54: 875-884 |
| Vabret N, Britton GJ, Gruber C, et al. (2020) Immunology of COVID-19: Current State of the Science. Immunity |
| Hegde S, Krisnawan VE, Herzog BH, et al. (2020) Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer. Cancer Cell. 37: 289-307.e9 |
| Panni RZ, Herndon JM, Zuo C, et al. (2019) Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies. Science Translational Medicine. 11 |
| Jiang H, Liu X, Knolhoff BL, et al. (2019) Development of resistance to FAK inhibition in pancreatic cancer is linked to stromal depletion. Gut |
| Jiang H, Hegde S, DeNardo DG. (2017) Tumor-associated fibrosis as a regulator of tumor immunity and response to immunotherapy. Cancer Immunology, Immunotherapy : Cii |